MetLife is an insurance - life business based in the US. MetLife shares (MET) are listed on the NYSE and all prices are listed in US Dollars. MetLife employs 45,000 staff and has a trailing 12-month revenue of around $67.6 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $74.52 |
|---|---|
| 52-week range | $56.52 - $76.90 |
| 50-day moving average | $71.44 |
| 200-day moving average | $68.48 |
| Wall St. target price | $85.03 |
| PE ratio | 26.0865 |
| Dividend yield | $2.08 (2.89%) |
| Earnings per share (TTM) | $2.89 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $74.52 from 2024-07-24
| 1 week (2024-07-18) | -1.15% |
|---|---|
| 1 month (2024-06-25) | 4.36% |
| 3 months (2024-04-25) | 3.64% |
| 6 months (2024-01-25) | 5.87% |
| 1 year (2023-07-25) | 20.74% |
|---|---|
| 2 years (2022-07-21) | N/A |
| 3 years (2021-07-23) | 30.34% |
| 5 years (2019-07-25) | 62.71% |
Valuing MetLife stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MetLife's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MetLife's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, MetLife shares trade at around 26x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
MetLife's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.1052. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MetLife's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MetLife's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.7 billion.
The EBITDA is a measure of a MetLife's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $67.6 billion |
|---|---|
| Operating margin TTM | 8.15% |
| Gross profit TTM | $14.9 billion |
| Return on assets TTM | 0.37% |
| Return on equity TTM | 7.82% |
| Profit margin | 3.5% |
| Book value | $39.87 |
| Market Capitalization | $53.6 billion |
TTM: trailing 12 months
Dividend payout ratio: 27.84% of net profits
Recently MetLife has paid out, on average, around 27.84% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.89% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MetLife shareholders could enjoy a 2.89% return on their shares, in the form of dividend payments. In MetLife's case, that would currently equate to about $2.08 per share.
While MetLife's payout ratio might seem fairly standard, it's worth remembering that MetLife may be investing much of the rest of its net profits in future growth.
MetLife's most recent dividend payout was on 9 September 2024. The latest dividend was paid out to all shareholders who bought their shares by 5 August 2024 (the "ex-dividend date").
MetLife's shares were split on a 1122:1000 basis on 6 August 2017. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1122 shares. This wouldn't directly have changed the overall worth of your MetLife shares – just the quantity. However, indirectly, the new 10.9% lower share price could have impacted the market appetite for MetLife shares which in turn could have impacted MetLife's share price.
Over the last 12 months, MetLife's shares have ranged in value from as little as $56.5157 up to $76.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MetLife's is 1.047. This would suggest that MetLife's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
MetLife, Inc. , a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.